Insertions in the human immunode... [Antimicrob Agents Chemother. 2005] - PubMed

loading

Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations. [J Infect Dis. 1999]
Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L, Appice A, Cavaliere R, Scarabaggio T, Angarano G. J Infect Dis. 1999 Aug; 180(2):568-71.
Antiretroviral Resistance Mutations (revised April 2001). [HIV Clin Trials. 2001]
Antiretroviral Resistance Mutations (revised April 2001).
International AIDS Society-USA Resistance Testing Panel, HIV InSite. HIV Clin Trials. 2001 Jul-Aug; 2(4):346-55.
Review Genotypic testing for human immunodeficiency virus type 1 drug resistance. [Clin Microbiol Rev. 2002]
Review Genotypic testing for human immunodeficiency virus type 1 drug resistance.
Shafer RW. Clin Microbiol Rev. 2002 Apr; 15(2):247-77.
Transmission of zidovudine resistant strains of HIV-1: the first wave. [AIDS. 2001]
Transmission of zidovudine resistant strains of HIV-1: the first wave.
Blower S. AIDS. 2001 Nov 23; 15(17):2317-8.
Review Prevalence of drug resistance mutations in Spain among both naive and pretreated patients. [Antivir Ther. 1999]
Review Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
Soriano V. Antivir Ther. 1999; 4 Suppl 3:57-63.

HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements. [Biochemistry. 2012]
HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements.
Agniswamy J, Shen CH, Aniana A, Sayer JM, Louis JM, Weber IT. Biochemistry. 2012 Apr 3; 51(13):2819-28. Epub 2012 Mar 20.
Current and Novel Inhibitors of HIV Protease. [Viruses. 2009]
Current and Novel Inhibitors of HIV Protease.
Pokorná J, Machala L, Rezáčová P, Konvalinka J. Viruses. 2009 Dec; 1(3):1209-39. Epub 2009 Dec 11.
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance. [Viruses. 2010]
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance.
Acosta-Hoyos AJ, Scott WA. Viruses. 2010 Jan 28; 2(2):372-394.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Insertions in the human immunodeficiency virus type 1 protease and reverse trans...
Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.
Antimicrob Agents Chemother. 2005 Jul ;49(7):2575-82.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed